Prematurity Clinical Trial
Official title:
Early DHA Supplementation in Very Low Birth Weight Infants
NCT number | NCT03192839 |
Other study ID # | 6039 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | July 1, 2017 |
Est. completion date | August 30, 2018 |
Verified date | May 2019 |
Source | Mead Johnson Nutrition |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This clinical trial will evaluate the effects of giving supplements of PUFA to premature infants.
Status | Completed |
Enrollment | 30 |
Est. completion date | August 30, 2018 |
Est. primary completion date | July 9, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 3 Days |
Eligibility |
Inclusion Criteria: - Very low birth weight infants weighing less than 1500 grams - Consent signed within 72 hours of life Exclusion Criteria: - Infants with know metabolic disorder - Infants with known congenital GI anomaly - Infants who are deemed to be inappropriate for enrollment per attending neonatologist |
Country | Name | City | State |
---|---|---|---|
United States | Rush University Medical Center | Chicago | Illinois |
United States | North Shore University Health System | Evanston | Illinois |
Lead Sponsor | Collaborator |
---|---|
Mead Johnson Nutrition | North Shore Research Institue |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Red Blood Cell polyunsaturated fatty acids (PUFA) levels | 2 weeks of age | ||
Secondary | Red Blood Cell PUFA levels | 8 weeks of age | ||
Secondary | Feeding tolerance | Full enteral feed of 120 kcal/kg/day | 8 weeks | |
Secondary | Incidence of necrotizing enterocolitis | 8 weeks | ||
Secondary | Incidence of bronchopulmonary dysplasia | 8 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03670732 -
CPAP vs.Unsynchronized NIPPV at Equal Mean Airway Pressure
|
N/A | |
Completed |
NCT05322161 -
Yoga in the NICU for Parents Study
|
N/A | |
Recruiting |
NCT04542096 -
Real Time Evaluation of Dynamic Changes of the Lungs During Respiratory Support of VLBW Neonates Using EIT
|
||
Recruiting |
NCT04911452 -
Creating a Calmer NICU: Optimizing Growth and Brain Development in Preterm Infants
|
N/A | |
Recruiting |
NCT02901652 -
NIPPV and nBiPAP Methods in Preterm Infants With Respiratory Distress Syndrome
|
N/A | |
Completed |
NCT02148965 -
Effects of Exercise During Pregnancy on Maternal and Child Health: a Randomized Clinical Trial
|
N/A | |
Terminated |
NCT02032511 -
Comparison of RAM Cannula Nasal Continuous Positive Airway Pressure Versus Infant Flow Nasal Continuous Positive Airway Pressure (NCPAP)
|
N/A | |
Completed |
NCT02273843 -
A Trial on Different Dosages of Vitamin D in Preterm Infants With Late-onset Sepsis
|
Phase 1 | |
Completed |
NCT01721629 -
Weaning of Nasal Continuous Positive Airway Pressure (CPAP) in Premature Infants
|
N/A | |
Terminated |
NCT01819532 -
Milking the Umbilical Cord Versus Immediate Clamping in Pre-term Infants < 33 Weeks
|
N/A | |
Completed |
NCT00951860 -
Assessment of Autonomic Maturation in Neonatal Period and Early Neural Development From a Longitudinal Prospective Cohort
|
N/A | |
Completed |
NCT01523769 -
Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants
|
N/A | |
Completed |
NCT01478711 -
Comprehensive Clinical Decision Support (CDS) for the Primary Care of Premature Infants
|
N/A | |
Completed |
NCT00787124 -
Transfusions and Nitric Oxide Level in Preterm Infants
|
||
Completed |
NCT00749008 -
Study of Generalized Movements for Early Prediction of Cerebral Palsy
|
N/A | |
Completed |
NCT00527956 -
Facilitation and Barriers to Breastfeeding in the NICU
|
N/A | |
Terminated |
NCT00486395 -
Will CPAP Reduce Length Of Respiratory Support In Premature Infants?
|
Phase 3 | |
Terminated |
NCT01208493 -
Dietary Protein in the Very-low-birth-weight Infant
|
N/A | |
Completed |
NCT03372590 -
NEO Rehab for Infants at Risk of Cerebral Palsy
|
N/A | |
Completed |
NCT00033917 -
Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial
|
Phase 3 |